ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,067Medicare Part D Prescriptions Filled, Including Refills

Rank: 83 out of 2604

$527K Total Retail Price of All Prescriptions

Rank: 180 out of 2604

334 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
56% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 334 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

22% of this provider’s 334 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

3% of this provider’s 8,708 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
LEVOTHYROXINE SODIUM 632 510 1 4
LISINOPRIL 520 428 2 3
FUROSEMIDE 488 424 3 8
OMEPRAZOLE 364 266 4 5
WARFARIN SODIUM 353 310 5 13
HYDROCODONE-ACETAMINOPHEN 352 218 S3 6 1
CITALOPRAM HBR 327 301 7 18
METOPROLOL TARTRATE 313 234 8 9
METFORMIN HCL 190 117 9 7
ATENOLOL 186 164 10 11
POTASSIUM CHLORIDE 175 160 11 16
HYDROCHLOROTHIAZIDE 170 122 12 10
GABAPENTIN 165 73 13 12
GLYBURIDE 151 117 R 14 83
METOPROLOL SUCCINATE 145 127 15 17
SUCRALFATE 129 114 16 209
PREDNISONE 122 107 17 34
AMLODIPINE BESYLATE 121 97 18 6
POLYETHYLENE GLYCOL 3350 115 113 19 42
SIMVASTATIN 111 73 20 2
ALLOPURINOL 107 93 21 35
PROAIR HFA 93 52 22 27
DIGOXIN 93 81 22 71
PRAVASTATIN SODIUM 93 78 22 14
DILTIAZEM 24HR ER 89 78 25 172
NAMENDA 87 87 26 37
IBUPROFEN 85 39 27 32
SERTRALINE HCL 85 68 27 23
VENTOLIN HFA 82 58 29 63
CLOPIDOGREL 82 79 29 39
BETAMETHASONE VALERATE 80 66 31 210
ISOSORBIDE MONONITRATE ER 79 69 32 38
PLAVIX 76 74 33 75
FLUTICASONE PROPIONATE 76 64 33 31
LANTUS 76 65 33 40
ZOLPIDEM TARTRATE 74 52 36 21
DONEPEZIL HCL 72 71 37 28
TERAZOSIN HCL 70 46 38 129
CIPROFLOXACIN HCL 65 61 39 59
AMITRIPTYLINE HCL 65 50 R 39 82
MECLIZINE HCL 65 60 39 155
LOVASTATIN 63 51 42 24
QUINAPRIL HCL 61 61 43 167
ALENDRONATE SODIUM 60 60 44 29
TRIAMTERENE-HCTZ 59 59 45 55
METHOCARBAMOL 59 32 R 45 153
ENALAPRIL MALEATE 59 50 45 50
VERAPAMIL ER 57 46 48 117
ATORVASTATIN CALCIUM 56 56 49 19
AZITHROMYCIN 54 45 50 33
ALBUTEROL SULFATE 52 52 51 93
DOXYCYCLINE HYCLATE 52 36 51 122
ETODOLAC 52 37 51 178
TRAMADOL HCL 50 35 54 15
RISPERIDONE 50 38 54 65
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 18, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.